186 related articles for article (PubMed ID: 36469134)
1. RhoC in association with TET2/WDR5 regulates cancer stem cells by epigenetically modifying the expression of pluripotency genes.
Thomas P; Srivastava S; Udayashankara AH; Damodaran S; Yadav L; Mathew B; Suresh SB; Mandal AK; Srikantia N
Cell Mol Life Sci; 2022 Dec; 80(1):1. PubMed ID: 36469134
[TBL] [Abstract][Full Text] [Related]
2. RhoC regulates radioresistance via crosstalk of ROCK2 with the DNA repair machinery in cervical cancer.
Pranatharthi A; Thomas P; Udayashankar AH; Bhavani C; Suresh SB; Krishna S; Thatte J; Srikantia N; Ross CR; Srivastava S
J Exp Clin Cancer Res; 2019 Sep; 38(1):392. PubMed ID: 31488179
[TBL] [Abstract][Full Text] [Related]
3. RhoC: a fascinating journey from a cytoskeletal organizer to a Cancer stem cell therapeutic target.
Thomas P; Pranatharthi A; Ross C; Srivastava S
J Exp Clin Cancer Res; 2019 Jul; 38(1):328. PubMed ID: 31340863
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog.
Ma Y; Yu W; Shrivastava A; Srivastava RK; Shankar S
J Cell Mol Med; 2019 Apr; 23(4):2719-2730. PubMed ID: 30712329
[TBL] [Abstract][Full Text] [Related]
5. Notch1 regulates the functional contribution of RhoC to cervical carcinoma progression.
Srivastava S; Ramdass B; Nagarajan S; Rehman M; Mukherjee G; Krishna S
Br J Cancer; 2010 Jan; 102(1):196-205. PubMed ID: 19953094
[TBL] [Abstract][Full Text] [Related]
6. RhoC regulates cancer stem cells in head and neck squamous cell carcinoma by overexpressing IL-6 and phosphorylation of STAT3.
Islam M; Sharma S; Teknos TN
PLoS One; 2014; 9(2):e88527. PubMed ID: 24533098
[TBL] [Abstract][Full Text] [Related]
7. LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway.
Shi D; Wu F; Mu S; Hu B; Zhong B; Gao F; Qing X; Liu J; Zhang Z; Shao Z
J Exp Clin Cancer Res; 2019 Aug; 38(1):375. PubMed ID: 31443665
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC/AKT/MAPK signaling pathway.
Yuan YH; Wang HY; Lai Y; Zhong W; Liang WL; Yan FD; Yu Z; Chen JK; Lin Y
Cell Commun Signal; 2019 Jan; 17(1):9. PubMed ID: 30683109
[TBL] [Abstract][Full Text] [Related]
9. RNF168 promotes RHOC degradation by ubiquitination to restrain gastric cancer progression via decreasing HDAC1 expression.
Xu Y; Feng Y; Sun Z; Li Q
Biochem Biophys Res Commun; 2021 Jun; 557():135-142. PubMed ID: 33865221
[TBL] [Abstract][Full Text] [Related]
10. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.
Nalls D; Tang SN; Rodova M; Srivastava RK; Shankar S
PLoS One; 2011; 6(8):e24099. PubMed ID: 21909380
[TBL] [Abstract][Full Text] [Related]
11. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
[TBL] [Abstract][Full Text] [Related]
13. The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer.
Li Z; Wang Y; Zhu Y; Yuan C; Wang D; Zhang W; Qi B; Qiu J; Song X; Ye J; Wu H; Jiang H; Liu L; Zhang Y; Song LN; Yang J; Cheng J
Mol Oncol; 2015 Jun; 9(6):1091-105. PubMed ID: 25704916
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic silencing of Rab39a promotes epithelial to mesenchymal transition of cervical cancer through AKT signaling.
Zou C; Fan J; He M; Xu Y; Wang K; Cai Y; Li M
Exp Cell Res; 2019 May; 378(2):139-148. PubMed ID: 30826396
[TBL] [Abstract][Full Text] [Related]
15. DCLK1 regulates pluripotency and angiogenic factors via microRNA-dependent mechanisms in pancreatic cancer.
Sureban SM; May R; Qu D; Weygant N; Chandrakesan P; Ali N; Lightfoot SA; Pantazis P; Rao CV; Postier RG; Houchen CW
PLoS One; 2013; 8(9):e73940. PubMed ID: 24040120
[TBL] [Abstract][Full Text] [Related]
16. Synergistic inhibition of aggressive breast cancer cell migration and invasion by cytoplasmic delivery of anti-RhoC silencing RNA and presentation of EPPT1 peptide on "smart" particles.
Kaushal N; Tiruchinapally G; Durmaz YY; Bao L; Gilani R; Merajver SD; ElSayed MEH
J Control Release; 2018 Nov; 289():79-93. PubMed ID: 30149048
[TBL] [Abstract][Full Text] [Related]
17. RNA Polymerase II-Associated Factor 1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions With PHF5A and DDX3.
Karmakar S; Rauth S; Nallasamy P; Perumal N; Nimmakayala RK; Leon F; Gupta R; Barkeer S; Venkata RC; Raman V; Rachagani S; Ponnusamy MP; Batra SK
Gastroenterology; 2020 Nov; 159(5):1898-1915.e6. PubMed ID: 32781084
[TBL] [Abstract][Full Text] [Related]
18. Re-expression of Selected Epigenetically Silenced Candidate Tumor Suppressor Genes in Cervical Cancer by TET2-directed Demethylation.
Huisman C; van der Wijst MG; Schokker M; Blancafort P; Terpstra MM; Kok K; van der Zee AG; Schuuring E; Wisman GB; Rots MG
Mol Ther; 2016 Mar; 24(3):536-47. PubMed ID: 26686387
[TBL] [Abstract][Full Text] [Related]
19. The role of RhoC in epithelial-to-mesenchymal transition of ovarian carcinoma cells.
Gou WF; Zhao Y; Lu H; Yang XF; Xiu YL; Zhao S; Liu JM; Zhu ZT; Sun HZ; Liu YP; Xu F; Takano Y; Zheng HC
BMC Cancer; 2014 Jul; 14():477. PubMed ID: 24986540
[TBL] [Abstract][Full Text] [Related]
20. Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics.
Dang H; Ding W; Emerson D; Rountree CB
BMC Cancer; 2011 Sep; 11():396. PubMed ID: 21929801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]